Vision RT to share new clinical data at the ASTRO 2016 Annual Meeting

23rd September 2016
Nicola Sheppey

London, UK. 24 September 2016 – Vision RT today announces it will be exhibiting at the ASTRO 2016 Annual Meeting in Boston, Massachusetts, later this month.

New data will be released at this meeting from a trial at the NCI-Accredited Lineberger Cancer Center at the University of North Carolina. These data show zero radiation-induced abnormalities in blood flow to the heart in all patients where Vision RT’s product was used in left breast radiotherapy. This contrasts with a previous study, using a different technique for similar patients, where 27% of patients exhibited heart damage. This data will be presented at an Industry Expert Theater session by Tim Zagar, MD. At the same session, David Gierga, PhD (Massachusetts General Hospital) will also present on the use of different techniques, including AlignRT, for reproducible breast cancer radiotherapy.

Throughout the meeting there will be live demonstrations on AlignRT for frameless stereotactic radiosurgery (SRS), and for Deep Inspiration Breath Hold (DIBH) breast treatments. Alongside the demonstrations there will be live presentations from clinical experts on the booth, covering breast cancer, stereotactic treatments including frameless SRS, and a variety of other clinical applications.